UNITY-NHL Trial ’s Follicular Lymphoma Cohort Meets Primary Endpoint of Improved ORR

Treatment with umbralisib monotherapy demonstrated improved overall response rates among patients with follicular lymphoma.

Source: CancerNetwork - October 30, 2019 Category: Cancer & Oncology Authors: Kristie L. Kahl Source Type: news